Compare WWD & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WWD | DGX |
|---|---|---|
| Founded | 1870 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8B | 20.5B |
| IPO Year | N/A | 1996 |
| Metric | WWD | DGX |
|---|---|---|
| Price | $311.12 | $176.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $295.18 | $196.69 |
| AVG Volume (30 Days) | 590.6K | ★ 942.1K |
| Earning Date | 02-02-2026 | 01-29-2026 |
| Dividend Yield | 0.36% | ★ 1.82% |
| EPS Growth | ★ 19.63 | 14.49 |
| EPS | 7.19 | ★ 8.51 |
| Revenue | $3,567,064,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $12.05 | $12.37 |
| Revenue Next Year | $8.43 | $3.52 |
| P/E Ratio | $43.31 | ★ $20.66 |
| Revenue Growth | 7.30 | ★ 13.74 |
| 52 Week Low | $146.82 | $148.70 |
| 52 Week High | $317.56 | $197.55 |
| Indicator | WWD | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 63.63 | 38.43 |
| Support Level | $286.36 | $174.48 |
| Resistance Level | $317.56 | $177.24 |
| Average True Range (ATR) | 7.52 | 2.51 |
| MACD | 0.76 | -0.61 |
| Stochastic Oscillator | 79.26 | 16.22 |
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.